Possible causes of hunger symptoms after taking Anamorelin for three days

Anamorelin (Anamorelin) is an oral growth hormone secretion promoter, mainly used to treat cancer-related cachexia and help improve patients' appetite and weight. However, some patients experience symptoms of "not hungry" or loss of appetite after taking this drug, which may be related to many factors. First of all, the mechanism of action of anamorelin is to stimulate appetite and metabolism by stimulating the release of growth hormone in the body, but each person's response to the drug has individual differences, and some patients may experience a temporary adaptation period, manifested by appetite fluctuations or temporary loss of appetite.

Secondly, the patient's own condition and complications may also cause loss of appetite. Cancer patients, especially those in the advanced stages, often suffer from digestive system discomfort, pain, nausea, fatigue and other symptoms, which can affect their normal desire to eat. Although Anamorelin can improve the symptoms of cachexia, it is not a universal solution. It takes a certain amount of time for the drug to take effect. If the patient feels not hungry in the early stages of taking it, it may be caused by the disease itself or the side effects of other drugs, and a comprehensive judgment is required.

In addition, anamorelin may cause certain side effects in the early stage of taking it, such as gastrointestinal reactions (nausea, stomach discomfort, etc.), and these discomforts will also indirectly affect the patient's appetite. These side effects usually occur over a short period of time and gradually lessen as the body adapts. Doctors usually recommend that patients communicate in a timely manner when adverse reactions occur, adjust the medication regimen, or provide supportive care to relieve symptoms and ensure the continuity and effectiveness of treatment.

Regarding price, anamorelin has not yet been approved for marketing in China, and patients need to purchase it through formal foreign channels. The original version produced by Japan's Ono Pharmaceutical is more expensive, about more than 3,000 yuan per box, while the generic version produced by Laos' Lucius is relatively cheap, priced at about more than 2,000 yuan. When purchasing and using drugs, patients should give priority to regular channels and use drugs rationally under the guidance of doctors to ensure safety and efficacy.

Reference materials:https://www.drugs.com/